More articles from Myeloproliferative Disorders

Bone marrow findings in Erdheim-Chester disease: increased prevalence of chronic myeloid neoplasms
Gaurav Goyal, Aishwarya Ravindran, Yuanhang Liu, Rong He, Mithun V. Shah, N. Nora Bennani, Mrinal M. Patnaik, Karen L. Rech, Ronald S. Go, Mayo Clinic Hisiocytosis Working Group

Haematologica Oct 2019, haematol.2019.234187; DOI: 10.3324/haematol.2019.234187
Disease progression in myeloproliferative neoplasms: comparing patients in accelerated phase with those in chronic phase with Increased blasts (<10%) or with other types of disease progression
Julia T. Geyer, Elizabeth Margolskee, Spencer A. Krichevsky, Daniele Cattaneo, Leonardo Boiocchi, Paola Ronchi, Francesca Lunghi, Joseph M. Scandura, Maurilio Ponzoni, Robert P. Hasserjian, Umberto Gianelli, Alessandra Iurlo, Attilio Orazi

Haematologica Sep 2019, haematol.2019.230193; DOI: 10.3324/haematol.2019.230193
Suppressive effects of anagrelide on cell cycle progression and the maturation of megakaryocyte progenitor cell lines in human induced pluripotent stem cells
Koji Takaishi, Masahiro Takeuchi, Shokichi Tsukamoto, Naoya Takayama, Motohiko Oshima, Kenji Kimura, Yusuke Isshiki, Kensuke Kayamori, Yutaro Hino, Nagisa Oshima-Hasegawa, Shio Mitsukawa, Yusuke Takeda, Naoya Mimura, Chikako Ohwada, Tohru Iseki, Sou Nakamura, Koji Eto, Atsushi Iwama, Koutaro Yokote, Chiaki Nakaseko, Emiko Sakaida

Haematologica Sep 2019, haematol.2018.214841; DOI: 10.3324/haematol.2018.214841
Oncogenic fusion protein BCR-FGFR1 requires BCR-mediated oligomerization and chaperonin Hsp90 for activation
Malalage N. Peiris, April N. Meyer, Katelyn N. Nelson, Ezra W. Bisom-Rapp, Daniel J. Donoghue

Haematologica Aug 2019, haematol.2019.220871; DOI: 10.3324/haematol.2019.220871
Mathematical modeling reveals alternative JAK inhibitor treatment in myeloproliferative neoplasms
Kaitlyn Shank, Andrew Dunbar, Priya Koppikar, Maria Kleppe, Julie Teruya-Feldstein, Isabelle Csete, Neha Bhagwat, Matthew Keller, Outi Kilpivaara, Franziska Michor, Ross L. Levine, Laura de Vargas Roditi

Haematologica Aug 2019, haematol.2018.203729; DOI: 10.3324/haematol.2018.203729
Masked polycythemia vera: analysis of a single center cohort of 2480 red cell masses.
Nabih Maslah, Juliette Soret, Christine Dosquet, Laetitia Vercellino, Célia Belkhodja, Marie-Hélène Schlageter, Bruno Cassinat, Jean-Jacques Kiladjian, Christine Chomienne, Stephane Giraudier

Haematologica Aug 2019, haematol.2018.215582; DOI: 10.3324/haematol.2018.215582
Deletion of miR-451 curbs JAK2(V617F)-induced erythrocytosis in polycythemia vera by oxidative stress-mediated erythroblast apoptosis and hemolysis
Huiyu Yao, Yue Ma, Lily Jun-shen Huang

Haematologica Aug 2019, haematol.2018.210799; DOI: 10.3324/haematol.2018.210799
Mixed myeloid chimerism and relapse of myelofibrosis after allogeneic stem cell transplantation
Samer A. Srour, Amanda Olson, Stefan O. Ciurea, Parth Desai, Qaiser Bashir, Betul Oran, Prithviraj Bose, Rohtesh Mehta, Keyur P. Patel, Naveen Pemmaraju, Naval Daver, Srdan Verstovsek, Richard E. Champlin, Uday R. Popat

Haematologica Jul 2019, haematol.2019.223503; DOI: 10.3324/haematol.2019.223503
Impact of clinical, cytogenetic, and molecular profiles on long-term survival after transplantation in patients with chronic myelomonocytic leukemia
Janghee Woo, Dae Ro Choi, Barry E. Storer, Cecilia Yeung, Anna B. Halpern, Rachel B. Salit, Mohamed L. Sorror, David W. Woolston, Tim Monahan, Bart L. Scott, H. Joachim Deeg

Haematologica Jul 2019, haematol.2019.218677; DOI: 10.3324/haematol.2019.218677
Multilevel defects in the hematopoietic niche in essential thrombocythemia
Ting Sun, Mankai Ju, Xinyue Dai, Huan Dong, Wenjing Gu, Yuchen Gao, Rongfeng Fu, Xiaofan Liu, Yueting Huang, Wei Liu, Ying Chi, Wentian Wang, Huiyuan Li, Yuan Zhou, Lihong Shi, Renchi Yang, Lei Zhang

Haematologica Jul 2019, haematol.2018.213686; DOI: 10.3324/haematol.2018.213686

More articles from Myeloproliferative Disorders

Pages